Quick Answer
Pyrithione-zinc shampoo has not been established to cause cancer in people when used as directed. The EU cosmetics ban concerned reproductive toxicity and legal exception requirements. A separate EU scientific assessment found up to 1% safe for the rinse-off anti-dandruff use it evaluated.1, 2
Pyrithione zinc and cancer evidence
Pyrithione zinc, also called zinc pyrithione or ZPT, is an active ingredient used for dandruff and seborrheic dermatitis. Its cancer evidence and the basis of the EU cosmetics ban are separate questions.
In its 2020 opinion, the European Commission's Scientific Committee on Consumer Safety (SCCS) reported no evidence of a cancer-causing effect in the oral and skin-exposure animal studies it reviewed. That is relevant safety evidence, although it is not a lifetime human study of every shampoo formulation or user group.1
The EU cosmetics ban and reproductive toxicity
The explanation has three parts. Dr. Eddie's narrative evidence review of pyrithione zinc discusses them together in section 2.3, Regulatory Context.6
1. A reproductive-hazard classification
Zinc pyrithione received a Category 1B reproductive-toxicity classification involving developmental effects in animal studies. Reproductive toxicity and cancer are different health endpoints. A hazard describes a substance's potential to cause harm. Risk considers the exposure involved: how much reaches the body, by which route, and under what conditions of use.6
2. A separate assessment of rinse-off use
The SCCS evaluated consumer exposure and concluded that zinc pyrithione at concentrations up to 1% was safe for the rinse-off anti-dandruff hair use it assessed. This was a conclusion about specified use conditions, not unrestricted exposure.1
3. Additional requirements for a cosmetics exception
EU cosmetics law required all conditions for an exception to be met. Alongside a favorable SCCS assessment, applicants had to establish that no suitable alternatives were available. The regulation states that this alternatives requirement had not been established, so zinc pyrithione was prohibited in cosmetics from March 1, 2022.2
This explains how the SCCS safety conclusion and the later cosmetics prohibition can coexist. The prohibition did not reverse the panel's assessment of the evaluated 1% rinse-off use.6
Limits of laboratory cancer research
Some laboratory studies have investigated zinc pyrithione as a possible anticancer compound. A 2017 study examined cultured cancer cells, cells obtained from leukemia patients and tested outside the body, and tumors grown in mice.4
Those experiments can identify a candidate for further research. They do not demonstrate that a zinc-pyrithione shampoo treats or prevents cancer in people, or that it is an alternative to chemotherapy. An effect on laboratory cancer cells also cannot, by itself, prove that an ingredient has no cancer risk. Product safety and clinical cancer treatment require their own evidence.4
Pyrithione zinc in US dandruff products
In the United States, pyrithione zinc is included in FDA OTC Monograph M032 for dandruff and seborrheic dermatitis. The monograph sets formulation and labeling conditions for OTC drugs; it is not individual FDA approval of every shampoo.3 For ingredient uses and product-selection details, visit our zinc pyrithione ingredient guide.
Side effects and product-specific use
Skin reactions
Skin irritation is a possible side effect. A product can also cause an allergic reaction in someone sensitive to one of its ingredients. Read the full ingredient list if you have a known allergy, and stop using a product that causes a reaction.5
Directions and frequency
- Frequency depends on the product, the condition being treated and your skin's response. Follow the product directions and any instructions your clinician has given you.
- Keep it out of the eyes, and rinse with water if contact occurs.
- Seek medical advice if symptoms worsen or fail to improve with directed use.
These are topical products, not products to swallow. Rinse-off shampoo and leave-on preparations have different directions; do not treat them as interchangeable.3, 5
Limits of infant-specific evidence
Adult studies and regulatory assessments do not fill every gap in infant-specific research. Dr. Eddie's review distinguishes established adult evidence from the limited direct infant trial and exposure data. Choose a product formulated for baby scalp care, and use the cradle-cap guide for the care routine and signs that need assessment.6
Happy Cappy and pyrithione zinc
Happy Cappy Medicated Shampoo & Body Wash contains pyrithione zinc 0.95% for relief of flaking, scaling, and itching associated with dandruff and seborrheic dermatitis. Its role is symptom control for those conditions. Follow the product directions.
Putting the evidence in perspective
When reading a safety claim, identify whether it concerns cancer, reproductive toxicity, a particular exposure, or a rule for selling cosmetics. The underlying evidence determines what each finding means for a finished product. The original regulatory documents and the more detailed evidence review are linked below.